America's chip independence isn't just business - it's a matter of national security. Government backing and massive incentives are driving this transformation, creating a powerful tailwind for these companies.
The US government is committing hundreds of billions in subsidies and incentives to build domestic chip capabilities. This represents one of the largest industrial policy initiatives in decades.
Taiwan's rejection of US relocation proposals has accelerated the urgency for domestic production. This geopolitical tension creates immediate opportunities for US-based semiconductor companies and equipment suppliers.
This basket's total market capitalisation is 2,826,197.83 (as provided) and is anchored by a few very large-cap stocks, creating a concentrated, lower-volatility profile. That structure tends to favour steadier performance compared with baskets weighted toward smaller-cap, higher-growth names.
INTC: $235.41B
GFS: $23.28B
LRCX: $282.98B
Taiwan's rejection of US proposals to relocate chip production has intensified America's push for semiconductor independence. This creates a powerful investment theme centred on companies essential to building domestic chip manufacturing capabilities, from foundries to equipment suppliers.
This group spans the entire semiconductor value chain, including US-based manufacturers, equipment suppliers, and even select international companies building facilities in America. These are long-term plays driven by national security interests and substantial government incentives.
Each company was handpicked by professional analysts for their strategic position in America's semiconductor ecosystem. Whether they're expanding domestic production, supplying critical equipment, or providing essential components, they're positioned to benefit from this multi-year national priority.
Taiwan's rejection of a US proposal to relocate its chip production highlights the challenges of securing the global supply chain. This reinforces the strategic imperative for the United States to build its own domestic semiconductor capabilities, creating opportunities for companies essential to that effort.
Veröffentlicht am Februar 11
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
GLOBALFOUNDRIES INC
GFS
Aktueller Kurs
$45.87
GlobalFoundries is a US-headquartered semiconductor foundry with a substantial manufacturing presence in the United States, making it central to domes...
GlobalFoundries is a US-headquartered semiconductor foundry with a substantial manufacturing presence in the United States, making it central to domestic chip production.
LAM RESEARCH CORP
LRCX
Aktueller Kurs
$254.15
Lam Research is a leading American supplier of wafer fabrication equipment, which is essential for building and outfitting new domestic semiconductor ...
Lam Research is a leading American supplier of wafer fabrication equipment, which is essential for building and outfitting new domestic semiconductor foundries.
Join Nemo FREE today and unlock every stock
Es dauert nur 60 Sekunden.
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Vollständige Analyse lesen
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 30.53 % zulegen.
11 von 14 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+30.53%
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
